Response to: ‘Tapering antirheumatic drugs in a resource-poor setting: real-world evidence’ by Haroon et al | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Correspondence response

Response to: ‘Tapering antirheumatic drugs in a resource-poor setting: real-world evidence’ by Haroon et al

Free

Authors

Elise van Mulligen Department of Rheumatology, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands PubMed articles Google scholar articles
Pascal H P de Jong Department of Rheumatology, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands PubMed articles Google scholar articles

Correspondence to Elise van Mulligen, Department of Rheumatology, Erasmus MC, Postbus 2040, 3000 CA Rotterdam, Zuid-Holland, The Netherlands; elise.vanmulligen{at}erasmusmc.nl

Citation

van Mulligen E, de Jong PHP

Response to: ‘Tapering antirheumatic drugs in a resource-poor setting: real-world evidence’ by Haroon et al

Annals of the Rheumatic Diseases 2022;81:e209.

Publication history

Received July 31, 2020
Accepted July 31, 2020
First published August 14, 2020.

Online issue publication

October 18, 2023

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.